retatrutide phase 2 type 2 diabetes weight loss 2024 π A triple-action once-weekly injection can significantly lower blood sugar and body in people with diabetes, a new 3 trial shows. is part of an emerging generation Retatrutide vs Tirzepatide (2026): Differences
Description
Rybelsus has now demonstrated proven cardiovascular risk reduction in the landmark SOUL trial (McGuire et al., NEJM 2025)
After five months on the drug, my tastes stayed the same
Heart trial: Reduced infarct size 30% post-ischemia
However, these options produce much weaker effects
Trial dosing should not be copied for personal use
